We have located links that may give you full text access.
Mifepristone Implementation in Primary Care: Clinician and Staff Insights from a Pilot Learning Collaborative.
Contraception 2023 September 12
OBJECTIVES: The ExPAND Mifepristone learning collaborative (ExPAND) aims to support community-based primary care providers in overcoming logistical barriers to mifepristone provision. This qualitative study describes clinician and staff perspectives on the impact of ExPAND in two federally qualified health center networks (FQHCs).
STUDY DESIGN: Researchers interviewed a purposive sample of clinicians, staff members, and clinic leaders from two participating Illinois FQHCs using an interview guide grounded in the Consolidated Framework for Implementation Research. We analyzed interview transcripts in batches using grounded theory to identify themes regarding the reception of ExPAND, and barriers to and facilitators of program implementation.
RESULTS: Participants (n=13) expressed strong support for the provision of mifepristone for miscarriage management at their clinic sites. Generally, they personally supported mifepristone for both miscarriage management and abortion care. Many participants felt that ExPAND reflected their clinics' values as it strengthens the primary care relationship, focuses on patient-centered care, and addresses disparities in access. Some barriers to implementation include a fear that providing abortion care would jeopardize FQHC funding, as well as logistical hurdles due to the COVID-19 pandemic.
CONCLUSIONS: Participants felt that providing mifepristone in primary care settings was an important service for their patients and that ExPAND helped achieve that goal. The learning collaborative model can be used to support FQHCs incorporating miscarriage and abortion care. The findings of this study emphasize that in the future, clinics participating in ExPAND would benefit from education around how FQHCs can provide mifepristone for abortion care while complying with federal funding restrictions.
IMPLICATIONS STATEMENT: Learning collaboratives like ExPAND Mifepristone can help prepare primary care clinics to provide mifepristone. Clinicians and staff describe a clear benefit of mifepristone integration to their patient populations. Participants report mifepristone integration aligns with clinic values around patient-centered care and improved access to care.
STUDY DESIGN: Researchers interviewed a purposive sample of clinicians, staff members, and clinic leaders from two participating Illinois FQHCs using an interview guide grounded in the Consolidated Framework for Implementation Research. We analyzed interview transcripts in batches using grounded theory to identify themes regarding the reception of ExPAND, and barriers to and facilitators of program implementation.
RESULTS: Participants (n=13) expressed strong support for the provision of mifepristone for miscarriage management at their clinic sites. Generally, they personally supported mifepristone for both miscarriage management and abortion care. Many participants felt that ExPAND reflected their clinics' values as it strengthens the primary care relationship, focuses on patient-centered care, and addresses disparities in access. Some barriers to implementation include a fear that providing abortion care would jeopardize FQHC funding, as well as logistical hurdles due to the COVID-19 pandemic.
CONCLUSIONS: Participants felt that providing mifepristone in primary care settings was an important service for their patients and that ExPAND helped achieve that goal. The learning collaborative model can be used to support FQHCs incorporating miscarriage and abortion care. The findings of this study emphasize that in the future, clinics participating in ExPAND would benefit from education around how FQHCs can provide mifepristone for abortion care while complying with federal funding restrictions.
IMPLICATIONS STATEMENT: Learning collaboratives like ExPAND Mifepristone can help prepare primary care clinics to provide mifepristone. Clinicians and staff describe a clear benefit of mifepristone integration to their patient populations. Participants report mifepristone integration aligns with clinic values around patient-centered care and improved access to care.
Full text links
Trending Papers
Monitoring Macro- and Microcirculation in the Critically Ill: A Narrative Review.Avicenna Journal of Medicine 2023 July
ASA Consensus-based Guidance on Preoperative Management of Patients on Glucagon-like Peptide-1 Receptor Agonists.Anesthesiology 2023 November 21
Common postbariatric surgery emergencies for the acute care surgeon: What you need to know.Journal of Trauma and Acute Care Surgery 2023 December 2
Sodium bicarbonate Ringer's solution for hemorrhagic shock: A meta-analysis comparing crystalloid solutions.American Journal of Emergency Medicine 2023 November 6
Association between postinduction hypotension and postoperative mortality: a single-centre retrospective cohort study.Canadian Journal of Anaesthesia 2023 November 22
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app